Won-Young Kim1,2, Heungsup Sung3, Sang-Bum Hong4, Chae-Man Lim4, Younsuck Koh4, Jin Won Huh4. 1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. 2. Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. 3. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 4. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Abstract
BACKGROUND: To evaluate the predictors of high flow nasal cannula (HFNC) failure in pneumocystis pneumonia (PCP) patients with acute respiratory failure (ARF). METHODS: Fifty-two non-HIV-related PCP subjects were divided into a HFNC success group (44%) and a HFNC failure group (who required mechanical ventilation (MV) despite HFNC application) (56%). The clinical characteristics and physiologic effects were retrospectively reviewed and compared between the groups. RESULTS: At baseline, the heart rate, alveolar-arterial PO2 difference [P(A-a)O2], Sequential Organ Failure Assessment (SOFA) score, and proportion of subjects who used vasopressors were significantly higher in the HFNC failure group than in the HFNC success group. The 60-day mortality was 52% in the HFNC failure group and 13% in the HFNC success group (P=0.004). The results of the multivariate analysis indicated that the baseline SOFA score was independently associated with HFNC failure (adjusted odds ratio, 1.74 per each score unit increase; 95% CI, 1.05-2.89; P=0.03). Repeated measures analysis of variance revealed that within 6 h of HFNC initiation, the mean PaO2/FiO2 ratio decreased and the mean P(A-a)O2 increased rapidly in the HFNC failure group. CONCLUSIONS: Patients with ARF due to PCP subjected to HFNC therapy should be carefully monitored, and particular attention should be paid to those who had organ dysfunction and did not show early oxygenation improvement.
BACKGROUND: To evaluate the predictors of high flow nasal cannula (HFNC) failure in pneumocystis pneumonia (PCP) patients with acute respiratory failure (ARF). METHODS: Fifty-two non-HIV-related PCP subjects were divided into a HFNC success group (44%) and a HFNC failure group (who required mechanical ventilation (MV) despite HFNC application) (56%). The clinical characteristics and physiologic effects were retrospectively reviewed and compared between the groups. RESULTS: At baseline, the heart rate, alveolar-arterial PO2 difference [P(A-a)O2], Sequential Organ Failure Assessment (SOFA) score, and proportion of subjects who used vasopressors were significantly higher in the HFNC failure group than in the HFNC success group. The 60-day mortality was 52% in the HFNC failure group and 13% in the HFNC success group (P=0.004). The results of the multivariate analysis indicated that the baseline SOFA score was independently associated with HFNC failure (adjusted odds ratio, 1.74 per each score unit increase; 95% CI, 1.05-2.89; P=0.03). Repeated measures analysis of variance revealed that within 6 h of HFNC initiation, the mean PaO2/FiO2 ratio decreased and the mean P(A-a)O2 increased rapidly in the HFNC failure group. CONCLUSIONS: Patients with ARF due to PCP subjected to HFNC therapy should be carefully monitored, and particular attention should be paid to those who had organ dysfunction and did not show early oxygenation improvement.
Authors: Byung Ju Kang; Younsuck Koh; Chae-Man Lim; Jin Won Huh; Seunghee Baek; Myongja Han; Hyun-Suk Seo; Hee Jung Suh; Ga Jin Seo; Eun Young Kim; Sang-Bum Hong Journal: Intensive Care Med Date: 2015-02-18 Impact factor: 17.440
Authors: Luciano C P Azevedo; Pedro Caruso; Ulysses V A Silva; André P Torelly; Eliézer Silva; Ederlon Rezende; José J Netto; Claudio Piras; Suzana M A Lobo; Marcos F Knibel; José M Teles; Ricardo A Lima; Bruno S Ferreira; Gilberto Friedman; Alvaro Rea-Neto; Felipe Dal-Pizzol; Fernando A Bozza; Jorge I F Salluh; Márcio Soares Journal: Chest Date: 2014-08 Impact factor: 9.410
Authors: J A Kovacs; J W Hiemenz; A M Macher; D Stover; H W Murray; J Shelhamer; H C Lane; C Urmacher; C Honig; D L Longo Journal: Ann Intern Med Date: 1984-05 Impact factor: 25.391
Authors: Amit Kansal; Wei Jun Dan Ong; Shekhar Dhanvijay; Arbe Tisha Pepito Siosana; Loraine Mae Padillo; Chee Keat Tan; Monika Gulati Kansal; Faheem Ahmed Khan Journal: BMC Pulm Med Date: 2022-09-16 Impact factor: 3.320